Cyclic peptides: A powerful instrument for advancing biomedical nanotechnologies and drug development

PC Martian, M Tertis, D Leonte, N Hadade… - … of Pharmaceutical and …, 2024 - Elsevier
Cyclic peptides have emerged as an essential tool in the advancement of biomedical
nanotechnologies, offering unique structural and functional advantages over linear peptides …

Carcinoid crisis in Lutetium-177-Dotatate therapy of neuroendocrine tumors: an overview of pathophysiology, risk factors, recognition, and treatment

SJ Sozio, W Raynor, MC Becker, A Yudd, JS Kempf - EJNMMI reports, 2024 - Springer
Abstract Purpose Lutetium-177-Dotatate (Lutathera®) is a combined radionuclide-peptide
that is FDA-approved for the treatment of well-differentiated, somatostatin receptor-positive …

Neuroendokrine Tumoren

S Krome - Onkologische Welt, 2023 - thieme-connect.com
Zur Behandlung gastrointestinaler neuroendokriner Tumoren (NET) sind 2 Formulierungen
des synthetischen Somatostatin-Analogons Octreotid erhältlich: schnell freigesetzte und …